Cargando…
Low-molecular-weight heparin in addition to low-dose aspirin for preventing preeclampsia and its complications: A systematic review and meta-analysis
BACKGROUND: In this systematic review, we aimed to investigate the efficacy and safety of adding low-molecular-weight heparin (LMWH) or unfractionated heparin to low-dose aspirin (LDA) started ≤16 weeks'gestation in the prevention of preeclampsia (PE) in high-risk women. METHODS: PubMed, Cochra...
Autores principales: | Zheng, Li, Xia, Binbin, Yuan, Yuan, Wang, Yuran, Wang, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780488/ https://www.ncbi.nlm.nih.gov/pubmed/36568564 http://dx.doi.org/10.3389/fcvm.2022.1073148 |
Ejemplares similares
-
Low-dose aspirin in the prevention of preeclampsia in twin pregnancies: A real-world study
por: Zhou, Qiongjie, et al.
Publicado: (2023) -
Aspirin for the prevention of preeclampsia: A systematic review and meta-analysis of randomized controlled studies
por: Wang, Yixiao, et al.
Publicado: (2022) -
Low-dose aspirin and rivaroxaban combination therapy to overcome aspirin non-sensitivity in patients with vascular disease
por: Khan, Hamzah, et al.
Publicado: (2022) -
Efficacy and safety of low-dose aspirin combined with low-molecular-weight heparin in treatment of preeclampsia: a meta-analysis and systematic review
por: Wu, Chunfeng, et al.
Publicado: (2021) -
286 Genetic, laboratory and clinical factors associated with low-dose aspirin failure in the prevention of preeclampsia
por: Rottenstreich, Amihai, et al.
Publicado: (2023)